EZM-0414

N/A

Report date: 2024/10/31 20:00:05
NME

Base Information

Drug NameEZM-0414
Drug Alias NameEZM-0414IPN-60210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase SETD2 inhibitors
TargetsHistone-lysine N-methyltransferase SETD2
Therapy Area/IndicationsMultiple MyelomaLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEpizyme Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpizyme Inc
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, Large B-Cell, Diffuse

Other Information

ATC CodeN/A
Related LinksN/A